Krónikus mieloid leukémia (CML): vizsgálatok itt: Kanada
10 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Edmonton, Montreal
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Montreal
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- St. John's, Toronto
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Edmonton, Toronto
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - No phaseTaking peopleA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Where
- London
- Életkor
- 6 év to 39 év
- People
- 330 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05702645 - 2. fázisCsak meghívásosA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Edmonton, Nova Scotia, Ottawa, Toronto
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1. fázisTaking peopleA Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00 - 1. fázisTaking peopleStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 242 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT04260022 - No phaseTaking peopleMyeloproliferative Neoplasms (MPNs) Patient Registry
- Where
- Toronto
- People
- 5000
- Run by
- University Health Network, Toronto
See details and how to joinNCT02760238